{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T13:54:50Z","timestamp":1781963690147,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["oooojournal.net","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.oooo.2024.07.002","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T06:34:51Z","timestamp":1720938891000},"page":"e95-e100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Anti\u2013TNF-\u03b1 induced mucous membrane pemphigoid-like disease"],"prefix":"10.1016","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2933-8174","authenticated-orcid":false,"given":"Giacomo","family":"Setti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Vaschieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Caramaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Magnoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Consolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierantonio","family":"Bellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2024.07.002_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103036","article-title":"Mucous membrane pemphigoid","volume":"21","author":"Du","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.oooo.2024.07.002_bib0002","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaad.2018.08.030","article-title":"Prevalence estimates for pemphigoid in the United States: a sex-adjusted and age-adjusted population analysis","volume":"80","author":"Wertenteil","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.oooo.2024.07.002_bib0003","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12026-017-8975-2","article-title":"Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol Res"},{"key":"10.1016\/j.oooo.2024.07.002_bib0004","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.3389\/fimmu.2019.02219","article-title":"A retrospective study of patient-reported data of bullous pemphigoid and mucous membrane pemphigoid from a US-based registry","volume":"10","author":"Lee","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.oooo.2024.07.002_bib0005","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/jdv.17397","article-title":"European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I","volume":"35","author":"Rashid","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.oooo.2024.07.002_bib0006","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/odi.12639","article-title":"Oral mucous membrane pemphigoid and pemphigus vulgaris-a retrospective two-center cohort study","volume":"23","author":"Sultan","year":"2017","journal-title":"Oral Dis"},{"key":"10.1016\/j.oooo.2024.07.002_bib0007","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jaad.2016.10.028","article-title":"Periodontitis in oral pemphigus and pemphigoid: a systematic review of published studies","volume":"76","author":"Jascholt","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.oooo.2024.07.002_bib0008","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/jdv.17395","article-title":"European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II","volume":"35","author":"Schmidt","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.oooo.2024.07.002_bib0009","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamadermatol.2013.1434","article-title":"Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid","volume":"149","author":"Bernard","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.oooo.2024.07.002_bib0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2133.2005.06998.x","article-title":"Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity","volume":"154","author":"Oyama","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.oooo.2024.07.002_bib0011","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.crohns.2013.01.009","article-title":"Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel disease","volume":"7","author":"Mocci","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.oooo.2024.07.002_bib0012","first-page":"11","article-title":"Increased serum IL-6, TNF-alpha and IL-10 levels in patients with bullous pemphigoid: relationships with disease activity","volume":"12","author":"D'Auria","year":"1999","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.oooo.2024.07.002_bib0013","article-title":"Paradoxical phenomena of bullous pemphigoid induced and treated by identical biologics","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.oooo.2024.07.002_bib0014","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archderm.142.11.1457","article-title":"Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients","volume":"142","author":"Canizares","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oooo.2024.07.002_bib0015","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/14728222.12.9.1085","article-title":"Targeting tumor necrosis factor alpha in psoriasis and psoriatic arthritis","volume":"12","author":"Fantuzzi","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.oooo.2024.07.002_bib0016","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jdcr.2015.12.006","article-title":"Etanercept-induced generalization of chronic, localized, anogenital bullous pemphigoid in a psoriatic patient","volume":"2","author":"Wilmer","year":"2016","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.oooo.2024.07.002_bib0017","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000243805","article-title":"Bullous pemphigoid during long-term TNF-alpha blocker therapy","volume":"219","author":"Bordignon","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.oooo.2024.07.002_bib0018","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1365-2230.2011.04102.x","article-title":"Drug-induced bullous pemphigoid: cases triggered by intravenous iodine and etanercept","volume":"36","author":"Kluk","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.oooo.2024.07.002_bib0019","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000318008","article-title":"Autoimmune bullous skin diseases occurring under anti-tumor necrosis factor therapy: two case reports","volume":"221","author":"Boussemart","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.oooo.2024.07.002_bib0020","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.4049\/jimmunol.179.7.4840","article-title":"Generation of Th1 and Th2 chemokines by human eosinophils: evidence for a critical role of TNF-alpha","volume":"179","author":"Liu","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.oooo.2024.07.002_bib0021","first-page":"24:16786","article-title":"From molecular insights to clinical perspectives in drug-associated bullous pemphigoid","author":"de Nicolas-Ruanes","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.oooo.2024.07.002_bib0022","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.3389\/fimmu.2017.01752","article-title":"BP180 is critical in the autoimmunity of bullous pemphigoid","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.oooo.2024.07.002_bib0023","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.oooo.2024.07.002_bib0024","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2165\/00002018-199717060-00004","article-title":"Causal or casual?","volume":"17","author":"Meyboom","year":"1997","journal-title":"Drug Safety"},{"key":"10.1016\/j.oooo.2024.07.002_bib0025","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2165\/11537780-000000000-00000","article-title":"Comparison of three methods (consensual expert judgement), (algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions","volume":"33","author":"Th\u00e9ophile","year":"2010","journal-title":"Drug Safety"},{"key":"10.1016\/j.oooo.2024.07.002_bib0026","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.4103\/jfmpc.jfmpc_831_21","article-title":"Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions","volume":"10","author":"Shukla","year":"2021","journal-title":"J Family Med Prim Care"},{"key":"10.1016\/j.oooo.2024.07.002_bib0027","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.93.6.2257","article-title":"Viruses, cytokines, antigens, and autoimmunity","volume":"93","author":"Gianani","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.oooo.2024.07.002_bib0028","first-page":"22:11241","article-title":"Autoinflammatory diseases and cytokine storms-imbalances of innate and adaptative immunity","author":"Marcuzzi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.oooo.2024.07.002_bib0029","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","article-title":"Molecular mimicry and autoimmunity","volume":"95","author":"Rojas","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.oooo.2024.07.002_bib0030","first-page":"15:782","article-title":"The role of viral infections in the onset of autoimmune diseases","author":"Sundaresan","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.oooo.2024.07.002_bib0031","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.19373","article-title":"Bullous pemphigoid with autoantibodies against full-length BP180 protein after COVID-19 infection","author":"Oya","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.oooo.2024.07.002_bib0032","article-title":"New-onset bullous pemphigoid in a COVID-19 patient","volume":"2021","author":"Olson","year":"2021","journal-title":"Case Rep Dermatol Med"},{"key":"10.1016\/j.oooo.2024.07.002_bib0033","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaci.2016.08.012","article-title":"Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes","volume":"139","author":"Riani","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.oooo.2024.07.002_bib0034","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jaad.2022.05.013","article-title":"Pemphigus vulgaris after COVID-19 infection and vaccination","volume":"87","author":"Zou","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.oooo.2024.07.002_bib0035","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/bjd.20890","article-title":"Bullous pemphigoid after SARS-CoV-2 vaccination: spike-protein-directed immunofluorescence confocal microscopy and T-cell-receptor studies","volume":"186","author":"Gambichler","year":"2022","journal-title":"Br J Dermatol"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440324003754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440324003754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T17:37:27Z","timestamp":1728409047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440324003754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2212440324003754"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2024.07.002","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti\u2013TNF-\u03b1 induced mucous membrane pemphigoid-like disease","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2024.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}